ICON Public Limited Company (ICLR)
| Market Cap | 14.19B |
| Revenue (ttm) | 8.10B |
| Net Income (ttm) | 599.48M |
| Shares Out | 76.36M |
| EPS (ttm) | 7.47 |
| PE Ratio | 24.87 |
| Forward PE | 14.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 905,324 |
| Open | 186.61 |
| Previous Close | 185.77 |
| Day's Range | 180.95 - 188.99 |
| 52-Week Range | 125.10 - 228.29 |
| Beta | 1.25 |
| Analysts | Buy |
| Price Target | 201.23 (+8.31%) |
| Earnings Date | Oct 22, 2025 |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient... [Read more]
Financial Performance
In 2024, ICLR's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price target is $201.23, which is an increase of 8.31% from the latest price.
News
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites f...
ICON Public Limited Company (ICLR) Presents at Jefferies London Healthcare Conference 2025 Transcript
ICON Public Limited Company ( ICLR) Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM EST Company Participants Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial Officer...
ICON plc to Present at the Jefferies London Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Jefferies London Healthcare Conference.
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
Invesco International Small-Mid Company Fund outperformed most in the real estate and consumer staples sectors due to stock selection. The fund's underweight in real estate also added to relative retu...
ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Steven Cutler Barry Balfe - CEO & D...
ICON Reports Third Quarter 2025 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Third Quarter 2025 Results.
ICON: Solid Fundamentals Trump Regulatory Headwinds
In H1 2025, ICON's net book-to-bill ratio dropped to its lowest value since at least 2016. However, this ratio could improve since macroeconomic uncertainty is vanishing. ICON has a repurchase program...
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Third Quarter 2025 Earnings Conference Call.
ICON Announces CEO Transition
DUBLIN--(BUSINESS WIRE)--ICON Announces CEO Transition.
ICON plc to Participate at Upcoming Investor Conferences
DUBLIN--(BUSINESS WIRE)--ICON plc to Participate at Upcoming Investor Conferences.
ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Barry Balfe - Chief Operating Officer Kate Haven - Vice President of Investor ...
ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery
Clinical research organization ICON plc ICLR stock is surging on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2025 sales guidance.
ICON: Lower Guidance Downside And Expanded Repurchase Plan
ICON may be relatively undervalued, trading at a ~10% discount to IQVIA and offering an attractive ~7% free cash flow yield that markets seem to be responding to now. The CRO sector faces near-term he...
ICON Announces Results of Annual General Meeting
DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
ICON Reports Second Quarter 2025 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Second Quarter 2025 Results.
ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisation...
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (ICLR 0.92%) by selling 16,096 shares. The transaction was valued at $2.58 million.
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awar...
ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?
The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to ...
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2025 Earnings Conference Call.
ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR
LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of...
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the William Blair 45th Annual Growth Stock Conference.
ICON releases its ICON Cares 2024 Report
DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2024 Report.
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma p...
ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive O...